Skip to main navigation Skip to search Skip to main content

Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial

  • Dotan Yogev
  • , Yael Weintraub
  • , Oren Ledder
  • , Manar Matar
  • , Alex Krauthammer
  • , Zivia Shavit-Brunschwig
  • , Amichay Rotstein
  • , Max E. Godfrey
  • , Amit Assa
  • , Raanan Shamir
  • , Dan Turner
  • , Nir Salomon
  • , Esther Orlanski-Meyer
  • , Dror S. Shouval*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A 6-week course of QingDai (Indigo naturlis) was safe and effective in inducing remission in an open-label study of pediatric patients with mild–moderate ulcerative colitis.

Original languageEnglish
Pages (from-to)2917-2920
Number of pages4
JournalInflammatory Bowel Diseases
Volume31
Issue number10
DOIs
StatePublished - 1 Oct 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved.

Keywords

  • Chinese medicine
  • colitis
  • complimentary medicine
  • herbal
  • treatment

Fingerprint

Dive into the research topics of 'Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial'. Together they form a unique fingerprint.

Cite this